mowel 500 mg comprimido revestido por película
tecnimede - sociedade técnico-medicinal, s.a. - micofenolato de mofetil - comprimido revestido por película - 500 mg - micofenolato de mofetil 500 mg - mycophenolic acid - genérico - duração do tratamento: longa duração
micafungina accord 100 mg pó para concentrado para solução para perfusão
accord healthcare, s.l.u. - micafungina - pó para concentrado para solução para perfusão - 100 mg - micafungina sódica 101.73 mg - micafungin - genérico - duração do tratamento: longa duração
voriconazol bradex 200 mg pó para solução para perfusão
bradex commercial and industrial pharmaceutical products s.a - voriconazol - pó para solução para perfusão - 200 mg - voriconazol 200 mg - voriconazole - genérico - duração do tratamento: longa duração
blincyto
amgen europe b.v. - blinatumomab - leucemia linfoblástica com células precursoras - linfoma - agentes antineoplásicos - blincyto is indicated as monotherapy for the treatment of adults with cd19 positive relapsed or refractory b precursor acute lymphoblastic leukaemia (all). patients with philadelphia chromosome positive b-precursor all should have failed treatment with at least 2 tyrosine kinase inhibitors (tkis) and have no alternative treatment options. blincyto is indicated as monotherapy for the treatment of adults with philadelphia chromosome negative cd19 positive b-precursor all in first or second complete remission with minimal residual disease (mrd) greater than or equal to 0. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with philadelphia chromosome negative cd19 positive b precursor all which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic haematopoietic stem cell transplantation. blincyto is indicated as monotherapy for the treatment of paediatric patients aged 1 year or older with high-risk first relapsed philadelphia chromosome negative cd19 positive b-precursor all as part of the consolidation therapy (see section 4.
cloridrato de valaciclovir
ranbaxy farmacÊutica ltda - cloridrato de valaciclovir - antiviroticos
hidroxiureia
ems s/a - hidroxiurÉia - antineoplasico
hydrea
bristol-myers squibb farmacÊutica ltda - hidroxiurÉia - outros antineoplasicos
thymoglobuline
sanofi-aventis farmacÊutica ltda - imunoglobulina de coelho anti-timócitos humanos - imunosupressor
valtrex
glaxosmithkline brasil ltda - cloridrato de valaciclovir - antiviroticos (inibe replicacao virotica)
herpstal
ems sigma pharma ltda - antiviroticos